Quantcast
Last updated on April 24, 2014 at 13:10 EDT

Latest Antidepressant Stories

2013-10-28 08:28:09

MASON, Ohio, Oct. 28, 2013 /PRNewswire/ -- Assurex Health, a leading personalized medicine company, announced today that the International Review of Psychiatry published an extensive review that validates the clinical use of pharmacogenomic testing to help predict patient response to psychiatric medications and improve treatment outcomes. The paper provides substantial evidence that psychiatric pharmacogenomic testing has proven clinical value in predicting how individual patients...

2013-10-20 23:00:53

Pathways Real Life Recovery is happy to announce that they are now offering genetic testing in order to help people find the medications that will help them properly. South Jordan, UT (PRWEB) October 20, 2013 Pathways Real Life Recovery is a business based solely on the premise of helping people. They take pride in helping anyone of any age, race, or gender live a healthier, happier life. In this vain, Pathways is happy to announce that they are now offering genetic testing. For those...

2013-10-17 23:31:18

Judge overseeing consolidated federal court litigation sets new hearing over lawsuits alleging that Zoloft, other antidepressants may cause birth defects. Resource4thePeople's national network of attorneys maintain offer of free consultations to families with children allegedly suffering birth defects after use of SSRIs during pregnancies. San Diego, CA (PRWEB) October 17, 2013 http://www.resource4thepeople.com/defectivedrugs/SSRI-Birth-Defects.html Resource4thePeople announced today...

2013-10-14 08:25:33

Drug Launches Will Not Offset a Decline in Major-Market Sales Caused By Increasing Generic Competition For Atypical Antipsychotics, According to a New Report from Decision Resources BURLINGTON, Mass., Oct. 14, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Dainippon Sumitomo Pharma/Sunovion/Takeda Pharmaceutical's atypical antipsychotic Latuda will experience significant uptake in the...

2013-10-09 16:23:49

PARIS, October 9, 2013 /PRNewswire/ -- Lancet Neurology, a prestigious journal in its domain, publishes in its last issue, an article entitled "Pitolisant versus placebo and modafinil in patients with narcolepsy: a double-blind randomised trial" authored by Y. Dauvilliers and others from the HARMONY I study group which proposes a novel treatment for this orphan disease. It is accompanied by a Commentary entitled "A need for new treatments in narcolepsy". Narcolepsy is a...

2013-10-07 13:16:40

This press release is in support of a presentation by Professor Gerard Sanacora on Sunday Oct. 6 at the 26th ECNP Congress in Barcelona, Spain Glutamergic agents may one day be used as a novel treatment for mood and anxiety disorders, new research presented at the 26th ECNP Congress suggests. "Our results suggest the glutamatergic system is a truly viable target for antidepressant Profug development," says Professor Gerard Sanacora, from the Yale School of Medicine, Connecticut, US....

Depression Linked To Elevated Parkinson's Risk
2013-10-03 11:38:00

Brett Smith for redOrbit.com - Your Universe Online Affecting about 1 in 500 individuals, Parkinson’s disease is a neurodegenerative condition marked by physical shaking or stiffness, and new research published in the journal Neurology has found a connection between depression and increased risk for the disease. In the study, a team of Taiwanese researchers followed over 22,000 adults for a decade and discovered that people diagnosed with depression were over three times more likely...

2013-10-02 23:04:21

On September 19, US District Judge ordered a Paxil birth defects lawsuit be transferred to Philadelphia Court of Common Pleas. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by alleged Paxil side effects. San Diego, CA (PRWEB) October 02, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively...

2013-10-02 08:30:29

MIAMI, Fla. and NEW YORK, N.Y., Oct. 2, 2013 /PRNewswire/ -- Noven Pharmaceuticals, Inc., today announced that 11 presentations, featuring data analyses from its Phase 3 pivotal trials that supported the recent U.S. Food and Drug Administration approval of Brisdelle(TM) (paroxetine capsules, 7.5 mg/day) for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, will be showcased at the 2013 Annual Meeting of The North American Menopause Society (NAMS) in...

2013-10-01 15:22:48

Flushed face, sweating, a sudden rush of heat. The hot flash, the bane of menopausal women, also can affect men who are undergoing hormone therapy for prostate cancer. But unlike in women, neither soy protein nor a common antidepressant provides relief for men, according to researchers at Wake Forest Baptist Medical Center. Hot flashes occur in approximately 80 percent of men who are undergoing hormone manipulation as treatment for prostate cancer. Hormone therapy reduces the levels of...